Finnrick, an independent testing programme, publishes 36 assays for WllyBIO: 27 met its Purity focus threshold (at least 99.5% purity, no more than 35% dosage deviation) and 9 did not. Most recent assay 5 Aug 2026.
WllyBIO operates from china, listed by Finnrick as "Trading". Source: Finnrick, https://www.finnrick.com/vendors/wllybio.
Finnrick-tested with insufficient data for grading. Tested across 1 peptide products with 1 total samples.
WllyBIO is listed as active with a standing warning against it. Finnrick Grade X. Finnrick avg score: 3.6/10 across 1 samples (1 products). Insufficient data for a reliable grade.
WllyBIO holds independent lab grade X, assigned across 1 graded sample, average score 3.6/10. That grade comes from an independent grader's own sampling, not from PeptideAtlas, and it describes the samples that grader obtained rather than every batch sold.
No independent third-party assay is on file for WllyBIO, and we have not yet compiled a profile of its own website. An untested vendor has not failed a test — this is an absence of evidence, not evidence against it.
| Product | Assays | Result |
|---|---|---|
| Retatrutide | 14 | 12 passed, 2 failed |
| Tirzepatide | 11 | 8 passed, 3 failed |
| GHK-Cu | 6 | 6 passed, 0 failed |
| BPC-157 | 5 | 1 passed, 4 failed |
Source: Finnrick, as published 2026-08-09. Pass and fail are Finnrick's classification against its own threshold, not ours.
| Status | Active, with a standing warning |
|---|---|
| Independent lab grade | X (1 samples) |
| Average grader score | 3.6/10 |
| Vendor type | Research-use supplier |
| Satisfaction | 0.4/5 |
|---|---|
| Delivery | 5/5 |
| Customer service | 5/5 |
| Packaging | 4.3/5 |
| Ease of purchase | 5/5 |
| Payment | 5/5 |
Scored out of 5 by the same independent grader, from its own buyers rather than from this site.
Treat WllyBIO with caution — it carries an active warning on this directory. Also on record: 36 Finnrick assays (27 passing, 9 failing its purity threshold); an independent lab grade of X.
Yes. Finnrick, an independent testing programme, publishes 36 assays for WllyBIO: 27 met its Purity focus threshold (at least 99.5% purity, no more than 35% dosage deviation) and 9 did not. Most recent assay 5 Aug 2026.
Similar vendors: Pura Peptides, Glamgurcraft Innovations Foreign Trade, Hazel, TCI, AKS Chem, Peptide Worldwide, Regenerative Research, Dragon Pharma.
Popular peptides: Semaglutide, Tirzepatide, Retatrutide, BPC-157, CJC-1295, Ipamorelin.
Other reviewed vendors: Wolverine Peptides Review, Wuhan Eusana Technology Peptides Review, Wuhan HongyouJie HYJ Peptides Review.